Fulgent Genetics (FLGT) Return on Capital Employed (2016 - 2026)
Fulgent Genetics (FLGT) posted Return on Capital Employed of 8.23% for Q2 2026, down 28.45% sequentially from 6.41% in Q1 2026, and down 181.0% YoY from 10.17% in Q2 2025.
Fulgent Genetics (FLGT) Return on Capital Employed (2016 - 2026) Analysis & Trends
Fulgent Genetics has reported Return on Capital Employed for 11 years, with the latest figure at 8.23% in Q2 2026.
- Quarterly Return on Capital Employed fell 181.0% year-over-year to 8.23% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 8.23% (down 181.0% YoY) and the FY2025 annual result came in at 8.05%, down 165.0% from the prior year.
- Return on Capital Employed fell to 8.23% in Q2 2026 per FLGT's latest filing, from 6.41% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 49.65% in Q1 2022 and troughed at 18.02% in Q3 2024.
- A 5-year average of 1.01% and a median of 6.26% in 2025 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2023 and 2025: Return on Capital Employed plunged 4924 bps in 2023, then soared 1177 bps in 2025.
- Over 5 years, Return on Capital Employed stood at 17.75% in 2022, then sank by 190 bps to 15.98% in 2023, then jumped by 60 bps to 6.41% in 2024, then gained by 23 bps to 4.9% in 2025, then plunged by 68 bps to 8.23% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 8.23%, 6.41%, and 4.9% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 8.30% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 6.42% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -13.91% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 14.57% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 10.49% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 68.60% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 17.55% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 49.80% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 8.97% |
| 10 | Fulgent Genetics | 557.44 Mn | 300.41 Mn | 25.68 Mn | -8.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -8.23% |
| Mar 31, 2026 | -6.41% |
| Dec 31, 2025 | -4.90% |
| Sep 30, 2025 | -6.26% |
| Jun 30, 2025 | -6.43% |
| Mar 31, 2025 | -6.27% |
| Dec 31, 2024 | -6.41% |
| Sep 30, 2024 | -18.02% |
| Jun 30, 2024 | -16.59% |
| Mar 31, 2024 | -16.64% |
| Dec 31, 2023 | -15.98% |
| Sep 30, 2023 | -2.12% |
| Jun 30, 2023 | -2.10% |
| Mar 31, 2023 | 0.41% |
| Dec 31, 2022 | 17.75% |
| Sep 30, 2022 | 27.49% |
| Jun 30, 2022 | 39.28% |
| Mar 31, 2022 | 49.65% |
| Dec 31, 2021 | 59.48% |
| Sep 30, 2021 | 76.62% |